HCPCS Level IIdrugActive
J1453
Fosaprepitant injection
BETOS: O1E
Effective: 2022-01-01
Referenced in 2 policies
Description
Injection, fosaprepitant, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Emend
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
1 MG
Billing Units
150.0000
22
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.